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Background: Pharmacotherapy for peritoneal adhesion prophylaxis has been a focus for intensive
research. Previous strategies included intravenous and intraperitoneal application of suitable pharma-
ceutical agents. However, success of these strategies in humans has been limited. Here we describe intra-
operative local injection of pharmaceuticals as a novel strategy for adhesion prophylaxis.
Methods: N ¼ 208 peritoneal lesions were created in 26 adult Wistar rats. In each animal, lesions on one
ﬂank were randomly chosen for treatment with locally injected prednisolone whereas the contralateral
side was injected with normal saline. Half of the animals were randomly selected for early adhesion
scoring after 3 days. Adhesions were scored after 10 days in the other animals.
Results: One animal randomized into the late group died peri-operatively. In the early analysis group, 27%
(14/52) of treated lesions were affected by adhesions, whereas 50% (26/52) of control lesions were
affected by adhesions. This difference was statistically signiﬁcant (p ¼ 0.02). In the late analysis group,
52% (25/48) of treated lesions were affected by adhesions, whereas 60% (29/48) of control lesions were
affected by adhesions. This difference did not reach statistical signiﬁcance.
Conclusions: These experiments provide proof of principle that intra-operative local injection of phar-
maceutical agents is a promising strategy for adhesion prophylaxis. Once sutiable agents become available
this could become as common as local anesthesia for pain reduction. However, the effect of injected
prednisolone diminishes before the vulnerable time-frame for adhesion formation closes. Therefore slow-
release formulations and other agents with longer effect will need to be investigated in the future.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Post-operative adhesions are a signiﬁcant source for patient
morbidity.1 Adhesions result from a cascade of biochemical events
that is initiated by surgical trauma.2 Each step in this cascade is
a rational target for pharmaceutical adhesion prophylaxis.3 In spite
of this, physical barriers remain the only licensed adjuncts for
adhesion reduction in the USA and Europe. Attempts at intravenous
and intraperitoneal application of pharmaceuticals such as steroids
are well described.4 However, despite intensive research for the
past three decades intravenous and intraperitoneal pharmaceutical
therapy for adhesion prophylaxis have so far not been successful ingham and Women’s Hospital,
Rajab).
ciates Ltd. Published by Elsevier Lthumans.5 Here we describe intra-operative local injection of
pharmaceutical agents as a novel strategy for adhesion prophylaxis.
2. Methods
2.1. Animals
AdultWistar rats (Charles River Laboratories, Sulzfeld, Germany) with a weight
range of 230e270 g were housed under laboratory conditions (temperature: mean
21 C  2 C standard deviation, humidity: mean 55%  10% standard deviation,
12:12-h light-dark-cycle). Food (10 mm pellets, Provimi Kliba AG, Kaiseraugst,
Switzerland) and tap water were always available ad libitum. Preoperatively, four
animals were kept per cage (1354G Eurostandard Type IV cages, Tecniplast
Deutschland Gmbh, Hohenpeibenberg, Germany). The cages were lined with 5 mm
by 5 mm by 1 mm wood chips (Abedd e lab & vet Service GmbH, Vienna, Austria).
Following surgery, the animals were single housed in separate cages (1291H Euro-
standard Type IIIHcages, Tecniplast Deutschland Gmbh, Hohenpeibenberg,
Germany) until postoperative day two to prevent cannibalization of the laparotomy
wounds. These cageswere linedwith unbleached chemical pulp (Paul Hartmann AG,d. All rights reserved.
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cage (1354G Eurostandard Type IV cages, Tecniplast Deutschland Gmbh, Hohen-
peibenberg, Germany) to allow for social interaction of the animals. All animals
received humane care in accordance with institutional guidelines.2.2. Operations
The surgical procedures were performed as described previously.6 Operations
occured under aseptic conditions in a dedicated animal operating theatre. Three sets
of instruments were rotated between the operations, with each set being autoclaved
while not in use. Anesthesia was induced using inhaled isoﬂurane (Abbott, Wies-
baden, Germany) with the animals breathing spontaneously. Analgesia was
provided using preoperative subcutaneous injection of buprenorphine (0.05mg/kg).
Anesthesia was provided using ketamine (100 mg/kg) and xylazine (5 mg/kg). The
animals were placed on a heating mat warmed to 38 C (ThermoLux Waermeun-
terlage, Witte þ Sutor GmbH, Murrhardt, Germany). After shaving with electrical
clippers (Favorita II, Aesculap AG, Tuttlingen, Germany), the surgical ﬁeld was dis-
infected (Softasept N, B Braun, Melsungen, Germany). Fenestrated sterile covers
(CardinalHealth, Voisins le Bretonneux, France) were applied to the surgical ﬁeld.
The operations were performed using powder-free gloves. The abdominal wall was
incised longitudinally in the midline over 4 cm. On each abdominal side wall, 4
ischemic experimental lesions were created. To this effect, the musculoperitoneal
tissue was lifted with a hemostat, which resulted in the formation of a tissue button.
The base of the buttons was ligated (Vicryl 3e0, Ethicon, Norderstedt, Germany). The
lesions had a diameter of 0.5 cm, were spaced 1 cm apart and aligned parallel to the
midline along an imaginary line through the mammary glands. In each rat, one side
was randomly chosen for treatment. On this side, the experimental lesions were
directly injected with 10 mg prednisolone (Solu-Decortin H 100, Merck KGaG,
Darmstadt, Germany) dissolved in 0.05 ml normal saline solution. The contralateral
side served as an internal control and experimental lesions on this side were
injected with an equivalent amount of normal saline. Following treatment of the
experimental lesions, the midline laparotomy was closed in two layers. The mus-
culoperitoneal layer was closed with a running suture (Vicryl 3e0, Ethicon, Nor-
derstedt, Germany) and the skin was closed with clips (Leukoclip SD, Smith &
Nephew GmbH Wound Management, Schenefeld, Germany). Postoperatively the
animals received analgesia with 0.05 mg/kg buprenorphine (Temgesic, Merck Sharp
and Dohme GmbH, Haar, Germany) subcutaneously every 6 h until postoperative
day two.2.3. Experimental design
N¼ 208 experimental lesions were created in 26 animals. 13 animals with a total
of n ¼ 104 experimental lesions were randomly assigned to the early analysis group
and 13 animals with n ¼ 104 experimental lesions were randomly assigned to the
late analysis group. The number of animals per group was chosen on the basis of
a power calculation. Previous experiments indicated that approximately 65% of
untreated experimental lesions form adhesions.6 N ¼ 51 experimental lesions are
required per group to detect a decrease in adhesion incidence from 65% of buttons in
the control group to 37.5% of buttons in the treatment group with power 0.8 at
signiﬁcance level of alpha <0.05. Therefore 13 animals with 4 experimental lesions
on each peritoneal side were required per group. At the time of the operation
experimental lesions on one side were randomly chosen for treatment with pred-
nisolone whereas the contralateral side was injected with normal saline and servedFig. 1. A. Adhesions in the early analysis group could uniformly be lysed with traction (arro
required sharp dissection.as internal control. Animals in the early group were sacriﬁced after 3 days. Animals
in the late group were sacriﬁced after 10 days.
2.4. Adhesion scoring
Animals were euthanized with carbon dioxide in a side room to limit anxiety
among the live animals. All experimental lesions were evaluated for the presence of
adhesions by a blinded investigator and immediately photo-documented (Olympus
Mju Mini, Olympus, Tokyo, Japan). The number of experimental lesions covered by
adhesions as well as the number of experimental lesions free from adhesions was
recorded.
2.5. Statistical analysis
Power analysis and signiﬁcance analysis using the Wilcoxon signed rank test
were performed using dedicated statistics software (JMP, Version 10; SAS Institute
Inc., Cary, NC).
2.6. Histology
Experimental lesions were excised en-bloc together with any adhesive tissue
and ﬁxed in 4% phosphate buffered formalin. After routine tissue processing,
sections were cut at 4e5 mm and stained with hematoxylin and eosin according to
standard protocols. Analysis of the histology was made in a blinded fashion before
the results were correlated with the treatment groups.
3. Results
Two animals randomized into the late analysis group died peri-
operatively due to complications from anesthesia and auto-
cannibalization of the midline laparotomy wound respectively.
The animal that died from anesthetic complications was replaced
since this death occured before an incision had been made. After 3
days, 27% (14/52) of treated lesions were affected by adhesions,
whereas 50% (26/52) of control lesions were affected by adhesions.
There were fewer adhesions on the treatment side in 8 animals, the
same number of adhesions on both sides in 4 animals and more
adhesions on the treatment side in 1 animal (Fig. 3a). The difference
in the early analysis group was statistically signiﬁcant (Table 1).
Adhesions in the early analysis group could uniformly be lysedwith
traction (Fig. 1a).
After 10 days, 52% (25/48) of treated lesions were affected by
adhesions, whereas 60% (29/48) of control lesions were affected by
adhesions. There were fewer adhesions on the treatment side in 5
animals, the same number of adhesions on both sides in 3 animals
and more adhesions on the treatment side in 4 animals (Fig. 3b).
The difference in the late analysis group was not statistically
signiﬁcant (Table 1). Adhesions in the late analysis group could not
be lysed with traction but required sharp dissection (Fig. 1b).w). B. Adhesions in the late analysis group were highly vascularized (arrowheads) and
Fig. 2. Histology of the experimental lesions demonstrated an intact monolayer of
regular appearing peritoneum (arrows), voluntary smooth muscle (#) and connective
tissue with blood vessels (*).
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peritoneum in lesions of both the control group and the treatment
group (Fig. 2). Lesions that had macroscopic adhesions attached to
them were notable for the presence of blood vessels (Fig. 2),
whereas lesions without macroscopic adhesions were avascular.
4. Discussion
Post-operative adhesions represent a serious problem.7 Phar-
macological therapy via the intravenous and intraperitoneal routes
was intensively studied during the past three decades.4 However,
no efﬁcacy has so far been proven in human patients. In a Cochrane
review, the effects of systemic steroids, intraperitoneal steroids,
intraperitoneal heparin, systemic promethazine and intraperito-
neal noxytioline were analyzed for changes in adhesion score.5 In
this analysis, an odds ratio of <1 denotes beneﬁt and p < 0.05
indicates a statistically signiﬁcant result. Systemic steroids had an
odds ratio of 0.30 [95% CI 0.08e1.15, p ¼ 0.08] for deterioration of
adhesion score in 87 patients. Intraperitoneal heparin had an odds
ratio of 0.87 [95% CI 0.32e2.35, p ¼ 0.8] for improvement of
adhesion score in 63 patients and odds ratio of 1.27 [95% CI
0.56e2.91, p ¼ 0.6] for deterioration of adhesion score in 92
patients. Systemic promethazine had an odds ratio of 0.56 [95% CI
0.22e1.43, p ¼ 0.2] for improvement of adhesion score in 75
patients and an odds ratio of 0.59 [95% CI 0.25e1.42, p ¼ 0.2] for
deterioration of adhesion score in 93 patients. Finally, intraperito-
neal noxytioline had an odds ratio of 0.55 [95% CI 0.17e1.76, p¼ 0.3]
for deterioration of adhesion score in 87 patients.Fig. 3. Line plots show the number of adhesions on the control side linked to the number of
group (B).In contrast, physical barriers have widely recognized efﬁcacy
and remain the only licensed adjuncts for adhesion reduction in the
USA and Europe.8,9 Here we introduce intra-operative local injec-
tion of pharmaceuticals as a novel strategy for adhesion prophy-
laxis. The advantage of local injection over systemic or
intraperitoneal application of pharmaceuticals is that areas affected
by operative peritoneal trauma can be speciﬁcally targeted.
Therefore a higher local concentration of the therapeutic agent can
be achieved without systemic side-effects. Furthermore systemic
application is limited by ischemia of the traumatized tissues. The
traumatized tissues are poorly perfused with circulating systemic
pharmaceutical agents due to swelling, sutures and disruption of
blood supply by hemostasis.10 These problems are solved by intra-
operative local injection of the pharmaceutical agent.
Corticosteroids such as prednisolone are potent anti-
inﬂammatory agents.11 This is the rationale for their use in adhe-
sion prophylaxis.3 Steroids have been studied for over three
decades as agents for adhesion prophylaxis.5 The two previously
employed strategies for delivery of steroids were either via the
systemic or intraperitoneal route. Using a new strategy, intra-
operative local injection of pharmaceutical agents, we show that
prednisolone signiﬁcantly decreases adhesion formation by post-
operative day 3 (Table 1). This early time-point was chosen for
analysis since a transient effect of the injected prednisolone was
expected. By post-operative day 10 the anti-adhesion effect was no
longer statistically signiﬁcant with the power available in our
animal experiment (Table 1). This indicates that the effect of intra-
operative locally injected prednisone diminishes before the
vulnerable time-frame for adhesion formation closes. Therefore
slow-release formulations and other pharmaceutical agents with
longer lasting effect will need to be investigated in the future.
Histological analysis by a blinded pathologist did not reveal any
signiﬁcant differences between the treatment group and the
control group except increased vascularity in experimental lesions
compared to the control group. The reason for this ﬁndingis the fact
that more adhesions formed in the control group, since vascularity
correlated exactly with the presence of macroscopic adhesions.
Adhesions are known to function as vascular grafts to the ischemic
tissue. This underscores that adhesions have an important physi-
ological function in supporting devitalized tissues with blood
vessels.
The current paper provides proof of the principle that adhesion
formation can be diminished by intra-operative local injection of
pharmaceutical agents. However, an important limitation of steroid
use for adhesion prophylaxis is that these agents decrease wound
healing and put anastomoses at risk. This limits the clinical indi-
cations for corticosteroids as anti-adhesive agents in human
patients. Prednisolone was used in the current study because we
intend to establish proof of principle for intra-operative local
injection of pharmaceuticals as a new drug delivery strategy foradhesions on the experimental side for the early analysis group (A) and the late analysis
Table 1
Experimental lesions affected by adhesions in the control and treatment groups.
Number of
analyzed
experimental
lesions
Experimental
lesions affected
by adhesions
in control
group/total
lesions in
control group
Experimental
lesions affected
by adhesions
in treatment
group/total
lesions in
treatment
group
Statistical
signiﬁcance
level
Early analysis
group
(t ¼ 3 d)
104 26/52 14/52 p ¼ 0.02
Late analysis
group
(t ¼ 10 d)
96 29/48 25/48 p > 0.05
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future other pharmaceuticals that are more clinically relevant,
including non-steroidal anti-inﬂammatory agents, ﬁbrinolytics,
anti-cytokine agents, statins and anti-proliferatives will need to be
studied as alternative agents for local injection.
5. Conclusion
Intra-operative local injection of pharmaceutical agents is
a promising new strategy for adhesion prophylaxis. However, it will
be necessary to identify pharmaceuticals with a sufﬁciently long
duration of action to cover the entire time-frame during which
tissues are vulnerable for adhesion formation.
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